ChiCTR2300075442 版本V1.1 版本创建时间2024/02/05 10:37:20 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300075442 

最近更新日期:

Date of Last Refreshed on:

2023-09-05 15:28:15 

注册时间:

Date of Registration:

2023-09-05 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

轻度创伤性脑损伤患者不良预后危险因素的预测研究

Public title:

Predictive study of risk factors for poor outcome in patients with mild traumatic brain injury

注册题目简写:

English Acronym:

研究课题的正式科学名称:

轻度创伤性脑损伤患者不良预后危险因素的预测研究

Scientific title:

Predictive study of risk factors for poor outcome in patients with mild traumatic brain injury

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

叶胜 

研究负责人:

叶胜 

Applicant:

Ye Sheng 

Study leader:

Ye Sheng 

申请注册联系人电话:

Applicant telephone:

+86 139 5534 2300

研究负责人电话:

Study leader's
telephone:

+86 139 5534 2300

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yesheng0553@163.com

研究负责人电子邮件:

Study leader's E-mail:

yesheng0553@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

安徽省芜湖市康复路10号

研究负责人通讯地址:

安徽省芜湖市康复路10号

Applicant address:

10 Kangfu Road, Wuhu City, Anhui Province, China

Study leader's address:

10 Kangfu Road, Wuhu City, Anhui Province, China

申请注册联系人邮政编码:

Applicant postcode:

241000

研究负责人邮政编码:

Study leader's postcode:

241000

申请人所在单位:

皖南医学院第二附属医院

Applicant's institution:

The Second Affiliated Hospital of Wannan Medical College

研究负责人所在单位:

皖南医学院第二附属医院

Affiliation of the Leader:

The Second Affiliated Hospital of Wannan Medical College

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

WYEFYLS2023095

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

皖南医学院第二附属医院伦理委员会

Name of the ethic committee:

The Ethics Committee of the Second Affiliated Hospital of Wannan Medical College

伦理委员会批准日期:

Date of approved by ethic committee:

2023-04-13 00:00:00

伦理委员会联系人:

王登纪

Contact Name of the ethic committee:

Wang Dengji

伦理委员会联系地址:

安徽省芜湖市康复路10号

Contact Address of the ethic committee:

10 Kangfu Road, Wuhu City, Anhui Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 553 287 1911

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

皖南医学院第二附属医院

Primary sponsor:

The Second Affiliated Hospital of Wannan Medical College

研究实施负责(组长)单位地址:

安徽省芜湖市康复路10号

Primary sponsor's address:

10 Kangfu Road, Wuhu City, Anhui Province, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

安徽省

市(区县):

芜湖市

Country:

China

Province:

AnHui province

City:

WuHu city

单位(医院):

皖南医学院第二附属医院

具体地址:

安徽省芜湖市康复路10号

Institution
hospital:

The Second Affiliated Hospital of Wannan Medical College

Address:

10 Kangfu Road, Wuhu City, Anhui Province, China

经费或物资来源:

芜湖市科技局自然科学基金

Source(s) of funding:

Natural Science Foundation of Wuhu Science and Technology Bureau

研究疾病:

创伤性脑损伤  

Target disease:

traumatic brain injury

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

诊断试验新技术临床试验 

Study phase:

Diagnostic New Technique Clincal Study

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

1、探究轻度创伤性脑损伤患者入院后即刻、30天血浆IL-1、IL-6、HMGB1、NSE、S100β、Ninjurin1变化; 2、探究轻度创伤性脑损伤患者30天认知功能、脑震荡症状、生活质量、抑郁状态变化;  

Objectives of Study:

1、To investigate the changes of plasma IL-1, IL-6, HMGB1, NSE, S100β and Ninjurin1 in patients with mild traumatic brain injury immediately and 30 days after admission. 2、To explore the changes of cognitive function, concussion symptoms, quality of life and depression status in patients with mild traumatic brain injury within 30 days.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)头面部闭合性外伤<24h; (2)GCS评分13-15分; (3)短暂意识丧失(<30分钟); (4)意识模糊或创伤后健忘(<24小时); (5)短暂性局灶性神经功能缺损; (6)年龄≥18岁; (7)头颅CT或MRI检查未见明显出血性病变。

Inclusion criteria

(1) Closed trauma with head and face less than 24 hours; (2) GCS score 13-15; (3) Transient loss of consciousness (<30 minutes); (4) Confusion or post-traumatic amnesia (<24 hours); (5) Transient focal neurological deficits; (6) Age ≥18 years; (7) No obvious hemorrhagic lesions were found in head CT or MRI.

排除标准:

(1)酒精、药物中毒引起的创伤性脑损伤; (2)口服抗凝剂; (3)口服精神类药物; (4)癫痫患者; (5)并发严重感染、免疫抑制剂治疗、多器官功能衰竭、血液系统疾病患者。

Exclusion criteria:

(1) Traumatic brain injury caused by alcohol or drug poisoning; (2) Oral anticoagulants; (3) Oral psychotropic drugs; (4) Patients with epilepsy; (5) Patients complicated with severe infection, immunosuppressive therapy, multiple organ failure, and hematological diseases.

研究实施时间:

Study execute time:

From 2023-05-01 00:00:00 To 2025-10-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-10-01 00:00:00 To 2025-10-01 00:00:00

干预措施:

Interventions:

组别:

mTBI组

样本量:

100

Group:

mTBI group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

对照组

样本量:

30

Group:

Control group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

安徽省 

市(区县):

芜湖市 

Country:

China

Province:

AnHui province

City:

WuHu city

单位(医院):

皖南医学院第二附属医院 

单位级别:

三甲 

Institution
hospital:

The Second Affiliated Hospital of Wannan Medical College

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

认知功能

指标类型:

主要指标

Outcome:

Cognitive function

Type:

Primary indicator

测量时间点:

测量方法:

简易精神状态检查量表

Measure time point of outcome:

Measure method:

mini mental-state examination, MMSE

指标中文名:

生活质量

指标类型:

次要指标

Outcome:

Quality of life state

Type:

Secondary indicator

测量时间点:

测量方法:

生活质量评定量表

Measure time point of outcome:

Measure method:

quality of life after brain injury-overall scale,QOLIBRI-OS

指标中文名:

脑震荡后症状

指标类型:

次要指标

Outcome:

Post-concussion symptoms

Type:

Secondary indicator

测量时间点:

测量方法:

脑震荡后症状问卷

Measure time point of outcome:

Measure method:

Post Concussion Symptom Questionnaire

指标中文名:

抑郁状态

指标类型:

次要指标

Outcome:

Depressive state

Type:

Secondary indicator

测量时间点:

测量方法:

贝克抑郁量表

Measure time point of outcome:

Measure method:

Beck depression inventory,BDI

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

项目组根据研究进程择期选择具体方式公开原始数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The research data should be made freely available to all researchers in specific ways according to the progress of the research.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

1、研究者根据受试者的原始观察记录,将数据及时、完整、正确、清晰地载入病例报告表,采用双人核对的方式录入数据库,之后对数据库进行比对; 2、电子数据文件分类保存,并有多个备份保存于不同磁盘或者记录介质上,妥善保存,防止损坏。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

1、The researcher promptly, completely, correctly, and clearly records the data from the subjects' original observation records into the case report form and adopts a double-checking method for data entry into the database. The database is then compared for accuracy. 2、The electronic data files are saved and classified, and multiple backups are stored on different disks or recording media to ensure safekeeping and prevent damage.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-09-05 15:27:51